AAAAAA
Results:
1-19
|
Results: 19
Authors:
Duong, M
Petit, JM
Piroth, L
Grappin, M
Buisson, M
Chavanet, P
Hillon, S
Portier, H
Citation: M. Duong et al., Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy, J ACQ IMM D, 27(3), 2001, pp. 245-250
Authors:
Duong, M
Piroth, L
Peytavin, G
Forte, F
Kohli, E
Grappin, M
Buisson, M
Chavanet, P
Portier, H
Citation: M. Duong et al., Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response, CLIN INF D, 33(3), 2001, pp. 386-392
Authors:
Thelot, B
Pialoux, G
Delhommeau, A
Piroth, L
Salmon-Ceron, D
Citation: B. Thelot et al., Hospital epidemiology of patients co-infected by HIV and HCV, MED MAL INF, 31(10), 2001, pp. 601-604
Authors:
Thelot, B
Pialoux, G
Delhommeau, A
Piroth, L
Salmon-Ceron, D
Citation: B. Thelot et al., Hospital epidemiology of patients co-infected by HIV and HCV, MED MAL INF, 31(10), 2001, pp. 605-608
Authors:
Piroth, L
Desbiolles, N
Mateo-Ponce, V
Martin, L
Lequeu, C
Charles, PE
Portier, H
Chavanet, P
Citation: L. Piroth et al., HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae, J ANTIMICRO, 47(1), 2001, pp. 33-42
Authors:
Duong, M
Buisson, M
Cottin, Y
Piroth, L
Lhuillier, I
Grappin, M
Chavanet, P
Wolff, JE
Portier, H
Citation: M. Duong et al., Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review, CLIN CARD, 24(10), 2001, pp. 690-694
Authors:
Desbiolles, N
Piroth, L
Lequeu, C
Neuwirth, C
Portier, H
Chavanet, P
Citation: N. Desbiolles et al., Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcusfaecalis and penicillin-resistant Streptococcus pneumoniae, ANTIM AG CH, 45(12), 2001, pp. 3328-3333
Authors:
Piroth, L
Grappin, M
Petit, JM
Buisson, M
Duong, M
Chavanet, P
Portier, H
Citation: L. Piroth et al., Incidence of gynecomastia in men infected with HIV and treated with highlyactive antiretroviral therapy, SC J IN DIS, 33(7), 2001, pp. 559-560
Authors:
Fromantin, C
Jamot, B
Cohen, J
Piroth, L
Pothier, P
Kohli, E
Citation: C. Fromantin et al., Rotavirus 2/6 virus-like particles administered intranasally in mice, withor without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response, J VIROLOGY, 75(22), 2001, pp. 11010-11016
Authors:
Grappin, M
Piroth, L
Kohli, E
Buisson, M
Duong, M
Chavanet, P
Portier, H
Citation: M. Grappin et al., Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice, J ACQ IMM D, 25(5), 2000, pp. 464-465
Authors:
Piroth, L
Grappin, M
Buisson, M
Duong, M
Portier, H
Chavanet, P
Citation: L. Piroth et al., Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy, J ACQ IMM D, 23(4), 2000, pp. 356-357
Authors:
Piroth, L
Grappin, M
Cuzin, L
Mouton, Y
Bouchard, O
Raffi, F
Rey, D
Peyramond, D
Gourdon, F
Drobacheff, C
Lombart, ML
Lucht, F
Besnier, JM
Bernard, L
Chavanet, P
Portier, H
Citation: L. Piroth et al., Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients, J VIRAL HEP, 7(4), 2000, pp. 302-308
Authors:
Piroth, L
Grappin, M
Sgro, C
Buisson, M
Duong, M
Chavanet, P
Citation: L. Piroth et al., Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient, ANN PHARMAC, 34(4), 2000, pp. 534-535
Authors:
Maillefert, JF
Tonolli-Serabian, I
Cherasse, A
Demoux, AL
Tavernier, C
Piroth, L
Citation: Jf. Maillefert et al., Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid, CLIN EXP RH, 18(2), 2000, pp. 255-256
Authors:
Grappin, M
Piroth, L
Verges, B
Sgro, C
Mack, G
Buisson, M
Duong, M
Chavanet, P
Portier, H
Citation: M. Grappin et al., Increased prevalence of subclinical hypothyroidism in HIV patients treatedwith highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1070-1072
Authors:
Petit, JM
Duong, M
Duvillard, L
Piroth, L
Grappin, M
Verges, B
Chavanet, P
Brun, JM
Portier, H
Citation: Jm. Petit et al., HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: A longitudinal study, HORMONE MET, 32(9), 2000, pp. 367-372
Authors:
Piroth, L
Grappin, M
Waldner, A
Sgro, C
Duong, M
Buisson, M
Chavanet, P
Portier, H
Citation: L. Piroth et al., Discontinuation of protease inhibitors due to intolerance: a longitudinal study in 309 HIV-1 positive patients, PRESSE MED, 28(8), 1999, pp. 381-387
Authors:
Piroth, L
Bourgeois, C
Dantin, S
Waldner, A
Grappin, M
Portier, H
Chavanet, P
Citation: L. Piroth et al., Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients, AIDS, 13(4), 1999, pp. 523-524
Authors:
Piroth, L
Martin, L
Coulon, A
Lequeu, C
Duong, M
Buisson, M
Portier, H
Chavanet, P
Citation: L. Piroth et al., Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics, ANTIM AG CH, 43(10), 1999, pp. 2484-2492
Risultati:
1-19
|